Showing results (551-560 of 577) with videos related to
Sort By:
Pageof 58
Mycokeys|July 6, 2026
Taxonomy and molecular evaluation of the Halosphaeriaceae (Microascales, Hypocreomycetidae)Monika C Dayarathne, E B Gareth Jones, Ali H Bahkali, et al.Journal of Managed Care & Specialty Pharmacy|July 5, 2023
Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defectsMatthew R Smith, Shahneen Sandhu, Daniel J George, et al.Journal of Biomolecular Screening|February 17, 2012
Lead discovery for microsomal prostaglandin E synthase using a combination of high-throughput fluorescent-based assays and RapidFire mass spectrometryMelanie V Leveridge, Ana Isabel Bardera, William LaMarr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2023
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate CancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.Future Oncology (London, England)|March 31, 2025
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancerKim N Chi, Dana Rathkopf, Matthew R Smith, et al.European Heart Journal|August 30, 2020
Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trialShouvik Haldar, Habib Rehman Khan, Vennela Boyalla, et al.Neurology|May 5, 2021
One-Stage, Limited-Resection Epilepsy Surgery for Bottom-of-Sulcus DysplasiaEmma Macdonald-Laurs, Wirginia J Maixner, Catherine A Bailey, et al.The Journal of Rheumatology|January 15, 2024
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine CareLykke M Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, et al.IMA Fungus|July 20, 2016
Recommendations for competing sexual-asexually typified generic names in Sordariomycetes (except Diaporthales, Hypocreales, and Magnaporthales)Martina Réblová, Andrew N Miller, Amy Y Rossman, et al.Pageof 58